EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases

Lifeng Li, Mingchao Li, Yihua Chen, Zengyuan Yu, Ping Cheng, Zhidan Yu, Weyland Cheng, Wancun Zhang, Zhaobao Wang, Xueyan Gao, Huiqing Sun, Xiaolei Wang

Frontiers in Microbiology · 06.02.2024 · 15

DOI: 10.3389/fmicb.2024.1354447 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 06.02.2024. Verfasst von Lifeng Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory of Children's Infectious Diseases, Department of Neonatology, Children's Hospital Affiliated to Zhengzhou Univer…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Henan Province, Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Akkermansia muciniphila is a gram-negative bacterium that colonizes the human gut, making up 3–5% of the human microbiome. A. muciniphila is a promising next-generation probiotic with clinical application prospects. Emerging studies have reported various beneficial effects of A. muciniphila including anti-cancer, delaying aging, reducing inflammation, improving immune function, regulating nervous system function, whereas knowledge on its roles and mechanism in infectious disease is currently unclear. In this review, we summarized the basic characteristics, genome and phenotype diversity, the influence of A. muciniphila and its derived components on infectious diseases, such as sepsis, virus infection, enteric infection, periodontitis and foodborne pathogen induced infections. We also provided updates on mechanisms how A. muciniphila protects intestinal barrier integrity and modulate host immune response. In summary, we believe that A. muciniphila is a promising therapeutic probiotic that may be applied for the treatment of a variety of infectious diseases.

Schlagwörter

Stichwörter der Autor:innen

Akkermansia muciniphilaimmune regulationinfectious diseasesintestinal floranext-generation probiotics

Autor:innen und Institutionen

  • Henan International Joint Laboratory of Children's Infectious Diseases, Department of Neonatology, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengz…
  • Electrical Biology Room, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.
  • Energy-rich Compounds Production by Photosynthetic Carbon Fixation Research Center, Shandong Key Lab of Applied Mycology, College of Life Sciences, Qingdao Agricultural University, Qingdao, China.
  • Medical Science and Technology Innovation Center, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • State Key Laboratory Cultivation Base, Shandong Provincial Key Laboratory of Ophthalmology, Eye Institute of Shandong First Medical University, Qingdao, China.

Förderung

  • Natural Science Foundation of Henan Province
  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Li, L., Li, M., Chen, Y., Yu, Z., Cheng, P., Yu, Z., Cheng, W., Zhang, W., Wang, Z., Gao, X., Sun, H., & Wang, X. (2024). Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1354447

Vancouver

Li L, Li M, Chen Y, Yu Z, Cheng P, Yu Z, et al. Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1354447

BibTeX
@article{Li2024,
  author = {Li, Lifeng and Li, Mingchao and Chen, Yihua and Yu, Zengyuan and Cheng, Ping and Yu, Zhidan and Cheng, Weyland and Zhang, Wancun and Wang, Zhaobao and Gao, Xueyan and Sun, Huiqing and Wang, Xiaolei},
  title = {Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1354447}
}
Kostenlos starten →